Silence Therapeutics (SLN) Other Non-Current Assets (2023 - 2025)
Historic Other Non-Current Assets for Silence Therapeutics (SLN) over the last 3 years, with Q3 2025 value amounting to $399000.0.
- Silence Therapeutics' Other Non-Current Assets fell 8567.68% to $399000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $399000.0, marking a year-over-year decrease of 8567.68%. This contributed to the annual value of $3.6 million for FY2024, which is 153.59% down from last year.
- Silence Therapeutics' Other Non-Current Assets amounted to $399000.0 in Q3 2025, which was down 8567.68% from $3.9 million recorded in Q2 2025.
- Silence Therapeutics' Other Non-Current Assets' 5-year high stood at $3.9 million during Q2 2025, with a 5-year trough of $399000.0 in Q3 2025.
- Moreover, its 3-year median value for Other Non-Current Assets was $3.2 million (2023), whereas its average is $3.0 million.
- Data for Silence Therapeutics' Other Non-Current Assets shows a peak YoY increase of 3130.42% (in 2025) and a maximum YoY decrease of 8567.68% (in 2025) over the last 5 years.
- Silence Therapeutics' Other Non-Current Assets (Quarter) stood at $3.2 million in 2023, then rose by 12.11% to $3.6 million in 2024, then plummeted by 88.89% to $399000.0 in 2025.
- Its Other Non-Current Assets stands at $399000.0 for Q3 2025, versus $3.9 million for Q2 2025 and $3.6 million for Q1 2025.